Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to demonstrate that there is a benefit in switching chronic
schizophrenic patients from conventional antipsychotic to olanzapine in terms of efficacy,
neurological safety and patient's outcome.